Latest filing published 04 Sept 2026 for Maze Therapeutics, Inc., €40k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Filings by Phillips Courtney span 2 companies, the busiest being Atreca, Inc. and Maze Therapeutics, Inc. The record holds 10 filings, for trades running from 9 September 2021 to 3 September 2026.
Every open-market trade on record is a sale: 7 sales worth €108k. Other entries cover 2 share grants and 1 option exercise. So far in 2026, the count stands at no purchases and 4 sales.
On 4 September 2026 came the latest disclosure, an open-market sale for €40k in Maze Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations